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Background: The European Commission Implementing Decision EU 2015/495 included three steroidal
estrogens, namely 17a-ethinyl estradiol, 17b-estradiol, and estrone, in the so-called “watch list” of the EU
Water Framework Directive (WFD). The monitoring of these compounds is difﬁcult because the detection
limits of the majority of the available analytical methods cannot achieve the very low target concen-
trations required to meet proposed environmental quality criteria. In 2014, a combined Science-Policy
Interface/Chemical Monitoring of Emerging Pollutants project was launched to meet this monitoring
challenge. The project involved 24 research organizations and environmental agencies from 12 different
countries.
Methods: Sixteen surface water (SW) and 17 wastewater (WW) samples were collected across Europe
and analysed using ﬁve in vitro effect-based and three chemical analytical methods. A general description
of the project and data evaluation is provided by K€onemann and colleagues in the companion publication
2018. In our study, we compared bioanalytical and chemical analytical results with regard to their
application for aquatic status assessment. Therefore we considered the potential to predict population-
relevant risks for aquatic organisms and the speciﬁcity and sensitivity of the various methods used incotoxicology Eawag-EPFL, Überlandstrasse 133, 8600 Dübendorf, Switzerland.
, kase.robert@googlemail.com (R. Kase).
ology Eawag/EPFL. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
R. Kase et al. / Trends in Analytical Chemistry 102 (2018) 343e358344both approaches. Finally, we tested and discussed the applicability and relevance of previously suggested
effect-based trigger values (EBT).
Results and discussion: Results of the risk assessment based on chemical analytical data correlated highly
with estrogenic activities (expressed as 17b-estradiol equivalents (EEQ) determined using effect-based
methods), demonstrating the ability of the bioassays to predict the mixture risk caused by steroidal
estrogens. For about 15% of SW and 40% of WW samples detection limits of chemical-analytical methods
were too high to allow a status assessment, while detection limits of all effect-based methods were
below proposed EBT. This demonstrates that effect-based methods are suitable for status assessment of
surface waters. The in vitro effect-based methods were quite speciﬁc for steroidal estrogens and highly
sensitive, meaning they have a low probability to detect false positive or negative results. After testing of
three alternative EBT proposals, we concluded to use preliminary 400 pg/L EEQ as screening EBT cor-
responding to the AA-EQS of E2. Further test speciﬁc reﬁnements in the application of this value are not
excluded.
Conclusions: We conclude that water quality assessment can progress from a purely analytical approach
to effect-based monitoring, from single substance to known and unknown mixture assessment and from
in vitro screening to population-relevant risk assessment. Despite a few limitations, effect-based in vitro
methods are recommendable for monitoring steroidal estrogens under the WFD because they, a) are able
to sensitively quantify the activity of steroidal estrogens in all surface and wastewater samples, b) are
able to detect the combined effect of estrogen mixtures including unknown chemicals with estrogen
receptor activating properties, c) allow an ecotoxicological status assessment using EBT to calculate risk
quotients. This approach is similar to the risk ratio used in regulatory environmental risk assessments,
but allows for an integrated mixture assessment.
Outlook: The results of this study support the introduction of a holistic approach for the regulation of
chemicals in the aquatic environment under the EUWFD, as proposed recently by EUWater Directors. An
ecotoxicological status assessment for one of the most relevant modes of action of endocrine disruption
will allow authorities responsible for water quality assessment to focus available monitoring resources
and to improve the ecological status of EU waterbodies.
© 2018 Swiss Centre for Applied Ecotoxicology Eawag/EPFL. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
1.1. State of the art and current regulation
Steroidal estrogens, which are commonly present in wastewa-
ters (WW) and surface waters (SW) (e.g. Ref. [1]), can cause
reproductive toxicity to aquatic biota, especially to ﬁsh [2e6]. The
most potent steroidal estrogens: the synthetic hormone 17a-ethi-
nyl estradiol (EE2), the natural hormones 17b-estradiol (E2), and
estrone (E1) the main transformation product of both, were
recently included in the European Union's watch list [7e9] of
substances for monitoring in SW. This watch-list mechanism is
designed to allow target EU-wide monitoring of substances of
possible concern to support the prioritization process in future
reviews of the priority substances list under the Water Framework
Directive (WFD). According to theWFD, the good chemical status of
awaterbody is reached when all substances included in the priority
list are detected below their deﬁned Environmental Quality Stan-
dards (EQS) that are based on annual average and maximum
allowable concentrations. The previously proposed and not regu-
latory binding annual average Environmental Quality Standards
(AA-EQS) for E1, E2 and EE2 are as low as 3600 pg/L, 400 pg/L and
35 pg/L, respectively [10,11]. So far, only a very limited number of
institutes from both the public and the private sector, and major
environmental agencies in Europe have developed capacities to
quantify the steroidal estrogens at their EQS levels. Such low EQS,
together with complexity of matrices such as SW and WW, and the
instability of some of the analytes, make the monitoring of these
compounds under the watch-list mechanism of the WFD and na-
tional surveillance schemes difﬁcult.
Estrogenic adverse effects in environmental watersare generally
caused by mixtures of different estrogenic chemicals including
metabolites, which increases their risk to wildlife [12]. A recentstudy demonstrated that mixtures of priority pollutants present at
and below their individual EQS concentrations can cause relevant
biological effects and may pose signiﬁcant risks to wild species and
ecosystems in spite of the fact that individual chemicals were at
concentrations in compliance with regulations [13]. Mixture
toxicity has also been highlighted in the context of the European
strategy on endocrine disrupting chemicals [14]. The European
Commission recently acknowledged the need to develop and
implement methodologies for the identiﬁcation of chemical
mixtures of potential concern and for the assessment of their
impacts on both environmental and human health [15]. Such
methodologies should help to link the knowledge of chemical
contamination and the observation of adverse effects on and via
the aquatic environment. For all described reasons (risks at low
concentrations, difﬁculty and costs of high-end analytics, mixture
toxicity, and linking chemical contamination to ecological status)
alternative monitoring and risk assessment methods are urgently
needed.
Effect-basedmethods detect cumulative effects and are useful to
bridge the gap between chemical contamination and ecological
status [16,17]. Complementary, mechanism-speciﬁc bioassays can
provide information onmodes of action (MoA) that are intrinsically
of concern for ecosystems and human health [18]. Focusing on
estrogenic effects, in vitro bioassays, can detect an activation of
estrogenic receptor(s) (ER) by mixtures of estrogens and xenoes-
trogens: In parallel, they can detect single analytes at sufﬁciently
low concentration levels [19]. The response of the assays is
expressed as E2-equivalent (EEQ) values. The applicability of this
approach has been demonstrated in different projects during the
past decade e.g. Refs. [20e23]. Also the combination of effect-based
and chemical analytical monitoring to identify and assess the risks
from steroidal estrogens has been discussed and proposed as a
potential tool for WFD monitoring [24e29].
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The WFD also involves evaluation of the ecological status of
waterbodies, e.g. monitoring of biological diversity. Consequently,
severe adverse effects at the population level of aquatic organisms
should be captured, but there are currently no tools under WFD
implemented tomonitor EndocrineDisruption efﬁciently. The current
proposal for theWFD [26e29a,b] is to screenwater samples by in vitro
assays for estrogenic activity and subsequently target the more
demanding chemical monitoring on a reduced number of samples
that show up as positive in the bioanalytical screening, as was previ-
ously elaborated by two international workshops in 2013 and 2017
[29a,b]. The water status evaluated with in vitro bioassays would be
newly called an ecotoxicological status for risk from ER-mediated ef-
fects and is intended to improve chemical and ecological status
assessment for one of themost relevantmodes of action of endocrine
disruption and ﬁsh reproduction toxicity [4]. As described, numerous
studies recommend the use of these effect-based methods. However,
clear recommendations for water managers regarding the use of
in vitro methods, especially as regards harmonized data evaluation
and effect-based trigger values (EBT) distinguishing “acceptable” and
“not acceptable” water quality are still missing.
Moreover, these methods with their clearly deﬁned EBT are also
necessary for wastewater management. Wastewaters or Waste-
water Treatment Plants (WWTPs) efﬂuents are the dominant
sources of steroidal estrogens in waterbodies, e.g. Refs. [30,31].
Therefore, although levels of estrogens in WW and WWTPs efﬂu-
ents are not directly regulated by the WFD, their monitoring is
necessary to quantify the loads emitted into waterbodies and to
show reduction of risks after having applied proper mitigation
actions. Various options for the removal of pharmaceuticals and
hormones by WWTPs were recently reviewed [24,32]. Although
elimination rates of estrogenicity (caused mainly by steroidal es-
trogens) at conventional WWTPs with tertiary treatment are high
(usually from about 80% to more than 90%, [33,34]) the residual
activity in discharges can still represent a risk for aquatic biota and
remains, besides untreated WW, their major known source [35].
Advanced treatment steps such as e.g. ozonation, UV treatment etc.
can further eliminate well above 90% of steroidal estrogens [32].
Under such circumstances, concentrations in surface waters cannot
be measured by most currently available chemical analytical
methods due to matrix effects [36].
To test if in vitro assays may be suited for regulatory monitoring
and risk assessment of low levels of estrogens in bothWWand SW,
24 research organizations and environmental agencies from 12
different European countries joined forces in a project, which also
supports the activities of theWorking Group “Chemicals” under the
Common Implementation Strategy (CIS) for the WFD and as a
follow-up to their “Science-Policy Interface” activity [17,37]. The
project results are summarized in two publications: the general
description of the project, experimental details and recommenda-
tions on harmonized in vitro data evaluation, are described in a
companion paper by K€onemann et al. [36]. The current publication
focuses on testing the most useful EEQ EBT for screening and dis-
cussion about environmental risk for SW and WW. A demonstra-
tion of applicability of the proposed EBT value to 16 SWand 17WW
samples collected across Europe is also presented here. The sam-
ples represented a gradient from low polluted to highly polluted
samples and were analysed by sensitive HPLC-MS/MS methods at
three different institutes and by ﬁve different in vitro assays at ﬁve
different institutes in order to:
 Evaluate the applicability and relevance of the in vitro methods
for the monitoring of steroidal estrogens with reference to the
classiﬁcation of the chemical status of waterbodies Discuss and recommend the extent to which the bioassays can
be used for screening and prioritizing environmental samples,
while considering risks for aquatic organisms
 Propose suitable effect-based trigger values (EBT) for screening
and discriminating between unpolluted and polluted samples
with the aim of classifying waterbodies.
 Contribute towards the review process ofWFD and to integrated
effect-based-methods (EBM) into regulation
Within this project, we aimed to bridge the gap between con-
ventional analytical and effect-based monitoring and risk assess-
ment for steroidal estrogens.
2. Methods
Sampling, sample preparation, positive and negative controls,
and chemical and biological analyses methods, are described in
detail in Ref. [36] and are brieﬂy summarized here.
2.1. Samples, sample preparation, in vitro and chemical analyses
A total of 16 SWand 17WW samples with 11 L sampling volume
were collected by 10 participating institutes at sites expected to be
polluted from Austria, Belgium, Czech Republic, Germany, France,
Italy and Spain. The samples were frozen within 48 h and sent to
Bio Detection Systems (BDS), Amsterdam, The Netherlands. Sam-
ples were ﬁltered (see K€onemann et al., 2018) and subsequently
extracted by using solid phase extraction with C18 cartridges
(Phenomenex Strata C18-E, 55 mm, 70 Å, 500 mg/6 mL). Additional
silica gel clean-up was applied to the extracts to reduce matrix
effects and reach detection limits in the sub ng/L range in the
chemical analysis. For some wastewater samples, a single silica gel
(SiOH) column was inadvertently used to treat the entire sample
extract (11 mL), while for each surface water sample, extract was
split into eleven 1 mL aliquots for clean-up. Extracts were then
homogenized, divided into 1 mL aliquots, and sent to Federal
Institute of Hydrology (BfG), Institut National de l'Environnement
Industriel et des Risques (INERIS), Research Centre for Toxic Com-
pounds in the Environment (RECETOX), and Helmholtz Centre for
Environmental Research (UFZ), where analyses by ﬁve in vitro
effect-based methods were performed: ER-Calux (at BDS), pYES,
MELN, HeLa 9903, and ER-GeneBlazer and to Joint Research Centre
(JRC), BfG, and Swiss Centre for Applied Ecotoxicology (Ecotox
Centre, EC) performing HPLCMS/MS analysis. EC used an additional
silica gel clean-up for 3 of 17 WW samples prior to the chemical
analysis. More detailed information on methods is available in the
companion publication K€onemann et al., 2018 [36]. All data were
analysed centrally in a harmonized way.
2.2. Chemical analytical data evaluation and compliance
assessment
Measured concentrations for E1, E2, and EE2 were expressed in
pg/L. Measurements below LOQ, but above LOD were indicated
as < LOQ. Measurements below LOD were indicated as < LOD (SI
Tables 1e3).
Themeasurements were comparedwith EQS proposals (AA-EQS
EE2 ¼ 35 pg/L, AA-EQS E2 ¼ 400 pg/L, AA-EQS E1 ¼ 3600 pg/L) in
order to assess potential compliance. Because the European Com-
mission did not propose an EQS for E1 [10] the Swiss EQS proposal
for E1 of 3600 pg/L [11] was used. The compliance of samples was
set to 0 if the measurement result exceeded an EQS proposal.
Compliance was designated as “not assessable” if the results were
below LOD, with an LOD (LOQ/3) above the EQS proposal. If EQS
proposals were not exceeded and LODs were below the proposed
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comparison reasons, the results for WW samples were treated the
same way as the SW samples, even though WW discharges are
usually diluted by the receiving waters. Only if concentrations of
estrogens in the ﬂow of the receiving waterbody and the efﬂuent
are known, dilution factors can be applied to calculate a ﬁnal
estrogenicity (Equation (8) in chapter 3.4.7.2) and the receiving
water can be assessed as compliant even though the WW could be
“non-compliant”. On the other hand in our project the concentra-
tions of estrogens in the receiving waters were not measured and
the precautionary principle (to set the same quality requirement
for WW and SW) was applied in order to avoid the risk of a false
negative assessment (extrapolation of compliance in case of non-
compliance) for the receiving waterbody. Our approach intends to
stimulate the consideration and measurements of background
concentrations without only focusing on the estrogenicity of the
WW discharges. The overall compliance corresponds to the
rounded average compliance to 0 or 1 of all three analytical
assessments.
2.3. Effect-based trigger values (EBT)
In recently published studies, a narrow concentration range of
published EBT values was proposed, although different approaches
were applied to derive them. The following shortly described EBT
were tested and discussed in our study in section 3.4.4:
Jarosova et al. [33] derived “safe environmental concentra-
tions” of EEQ in municipal wastewater efﬂuents, based on a
simpliﬁed assumption that mainly (>90%) steroidal estrogens are
causing ER-mediated estrogenicity. These potentially safe con-
centrations were derived using the estrogenic relative potencies
in bioassays, the in vivo predicted no-effect concentrations of the
compounds, and their relative contributions to the measured EEQ
of WW efﬂuents. The predicted safe concentrations ranged from
100 to 400 pg/L EEQ with a median EBT of 300 pg/L EEQ. We used
in our study the median EBT because we worked with ﬁve
different bioassays which we intended to characterize with
alternative EBT proposals.
Van der Oost at al [38]. used bioanalytical equivalents (BEQ) of
selected substances that trigger the bioassay and a background BEQ
to derive an EBT of 500 pg/L EEQ. The background BEQ was calcu-
lated with 60 pg EEQ/L, and a safe BEQ (based on lowest NOEC of
triggering substances) was 7 pg/L EEQ. The ﬁnally proposed EBT
(500 pg/L EEQ) was mainly based on a BEQ-converted species
sensitivity distribution (SSD) that provided the concentration that
is a potential hazard for 5% of aquatic species (HC5 BEQ ¼ 500 pg/L
EEQ).
Kase et al. and Kunz et al. [25,26] proposed to use the proposed
AA-EQS of E2 as an EBT for estrogen receptor mediated estrogenic
activity, thus proposed 400 pg/L EEQ as EBT. This was done pri-
marily for different reasons: a) The EBT is compatible with the EU
AA-EQS proposal for E2 which is based on ﬁsh toxicity SSD for
population relevant effects 400 pg/L EEQ, b) E2 is a natural steroid
hormone and has an in vitro and in vivo potency between E1 and
EE2, therefore it is likely better suited than E1 or EE2 for assessing
mixture effects, c) E2-equivalents are commonly used in bio-
analysis and biomonitoring, thus data are easily comparable with
previous studies, d) EE2 has a slightly higher potency in vitro than
E2, but in vivo it is 10e20 times more potent. If EE2 equivalents
were to be used, there is a high probability for risk overestimation
and obtaining false positive results, due to the possibility of E2 and
E1 playing a more prominent role. e) Steroidal estrogens normally
occur as a mixture in WW and in receiving waterbodies. Jarosova
and colleagues [33] compiled data of 353 wastewater measure-
ments from three studies with a median concentration of 7e12 ng/L E1, 1.3e1.7 ng/L E2 and 0.47e0.6 ng/L EE2. Based on relative po-
tencies of used bioassays this means that the in vitro ER mediated
mixture effect is likely dominated by E2. Therefore as a simpliﬁed
approach the use of 400 pg/L EEQ as EBT seem to be arbitrary,
however this can be justiﬁed and was successfully tested in this
study.
2.4. Effect-based compliance assessment and validation status of
methods
The measured EEQs were compared with EBTs to assess the
potential compliance of samples. The compliance of samples was
set to 0 (“non-compliant”) if the measured EEQ exceeded an EBT.
The compliance assessment was set to “not assessable” if LOQ or
LOD were above the EBT, but this never occurred during the mea-
surements. If EBT were not exceeded and LOD were below EBT the
compliance was set to 1 (“compliant”). The overall compliance
corresponds to the rounded average compliance to 0 or 1 of all ﬁve
effect-based assessments. After EBT discussion in section 3.4.4 we
used the 400 pg/L EEQ as preliminary EBT for compliance
assessment.
Validation activities: Two of our ﬁve in vitro assays used in this
study are currently being OECD validated (HeLa 9903 and ER-Calux
[39]) and the ER-Calux, A-YES and L-YES are DIN/EN/ISO stan-
dardized in 2018. The ER-ER-GeneBlazer is used in the US within
the Tox21 program of the National Institute of Health and US
Environmental Protection Agency [40].
2.5. Sensitivity and speciﬁcity analysis for methods in compliance
assessments
Sensitivity and speciﬁcity were determined for both chemical
and effect-based techniques. This was done to evaluate their suit-
ability for European WFD monitoring programs. High sensitivity
means that the method is less prone to detect false negatives, in
other words the method has a low risk of erroneous compliant
assessments. While high speciﬁcity means that the method is less
prone to detect false positives, in other words themethod has a low
risk of erroneous non-compliant assessments.
In order to assess the sensitivity and speciﬁcity of three chem-
ical analytical and ﬁve in vitro effect-based methods, each method
was compared with the overall compliance derived from the
chemical or effect-based analyses (see section 2.2 and 2.4)
Four options regarding conformity in the results of the com-
parison of the speciﬁc method with the overall compliance were
possible:
 Overall compliance is 1 and the compliance of the speciﬁc
method is 1, this means “conformity in compliance ”:¼ CC
 Overall compliance is 1 and the compliance of the speciﬁc
method is 0, this means “non-conformity in compliance”:¼ NCC
 Overall compliance is 0 and the compliance of the speciﬁc
method are 0, this means “conformity in non-
compliance”:¼CNC
 Overall compliance is 0 and the compliance of the speciﬁc
method is 1, this means “non-conformity in non-
compliance”:¼NCNC
Based on the conformity rating of each method sensitivity and
speciﬁcity was calculated according to Equations (1) and (2).
Sensitivity ½% ¼
P
CNC
ðPCNCþPNCCÞ*100 (1)
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P
CC
ðPCCþPNCNCÞ*100 (2)
2.6. Risk quotient and -scenario calculations for chemical and
ecotoxicological status assessments
The chemical analytical Risk Quotient (RQchem) was calculated
by dividing the Measured Environmental Concentration (MEC) by
the proposed EQS (Equation (3)). The biological RQbio was
calculated by dividing the measured Bioanalytical Equivalent
Concentration (BEQ), in our case Estradiol Equivalent
Concentration (EEQ) by the effect-based trigger value (EBT)
(Equation (4)). RQ > 1 signiﬁes an unacceptable risk for aquatic
organisms.
RQchem ¼
Measured Environmental Concentration ðMECÞ
Proposed EQS
(3)
RQeffectbased ¼
EEQ
Proposed EBT
(4)
The chemical analytical RQ is used for chemical status assess-
ment and the effect-based RQ for an eco-toxicological status
assessment. After EBT discussion in section 3.4.4 we used the
0.4 ng/L EEQ as preliminary EBT. Equation (3) for single analytes,
can be adapted to mixture effects of multiple measured substances
with the same MoA, via calculation of cumulative RQs, according to
Kortenkamp 2007 [41]. Kortenkamp proposed the concentration
addition concept as an accurate approach for regulatory use if EDC
have the same MoA (Equation (5)).
X
RQE1; E2; EE2 ¼
MEC E1
3600 pg=L
þ MEC E2
400 pg=L
þMEC EE2
35 pg=L
(5)
The application of this mixture concept is well supported by
additional evidence for endocrine disruptors and other relevant
mixtures [42,43]. Moreover, the equation can be further
improved to consider unknown unquantiﬁed risks by taking into
account the speciﬁc LODs and LOQs of chemical analytical
methods, i.e. by setting concentrations of samples with non-
detectable analytes either to 0, LOD/2 of LOD. Three cumulative
risk scenarios were calculated in this way to derive the minimum
known, the likely, and the maximal risks of steroidal estrogens in
the samples:
Mixture risk scenarios for chemical analytical methods:
1) Minimal cumulative risk scenario:
P
RQEE2, E2, E1 ¼
P
(MECEE2,
E2, E1/AA-EQSEE2, E2, E1)
2) Medium cumulative risk scenario:
P
RQEE2, E2, E1 ¼
P
(MECEE2,
E2, E1 or LOD/2EE2, E2, E1/AA-EQSEE2, E2, E1)
3) Maximal cumulative risk scenario:
P
RQEE2, E2, E1 ¼
P
(MECEE2,
E2, E1 or LODEE2, E2, E1/AA-EQSEE2, E2, E1)
The cumulative RQs for these three risk scenarios are based on
the chemical measurements (SI Tables 1e3).
2.7. Correlation analysis of risk quotients and EEQ measurements
We compared the chemical analytical mixture risk scenarios
with effect-based biological responses. Cumulative RQs of the
minimum and maximum risk scenarios were plotted on a loga-
rithmic scale against the biological EEQ (BEQ) responses and a log-
linear regression line (y ¼ axb) was calculated. Data were tested forlog-linearity (scatter-plot), constant variance (TA-plot) and
normality (Q-Q plot). Moreover, a double-sided correlation analysis
signiﬁcance test was performed with the Pearson correlation co-
efﬁcient at p  0.0001; p  0.001, p  0.01 and p  0.05 [44]. More
speciﬁc p-values and conﬁdence intervals were calculated with
graph pad 5 using a two-tailed column Pearson normality test after
normality check.2.8. Calculation of a risk indication score (RIS) and screening score
for effect-based methods
To measure how precisely a biological response indicates a
population relevant mixture risk, we calculated a Risk Indication
Score (RIS). A chemical analytical cumulative RQmix > 1 (Equation
(5) above) for estrogens indicates an “unacceptable” risk for aquatic
organisms and their populations. This is mainly the case for ﬁsh
species as, based on current knowledge, they include the most
sensitive species for estrogenic effects and were used to derive the
EQS. RQmix was compared to exceedances of EEQ measured by
effect based methods of different EBT (see chapter 2.3) ranging
from 300 to 500 pg/L.
There were two possible outcomes:
 If the cumulative chemical RQE1E2EE2 was >1 and the respective
EBT was exceeded by the biological response, it was counted as
successful risk indication.
 If the cumulative chemical RQE1E2EE2 was >1 and the respective
EBT was not exceeded by the biological response, it was counted
as failed risk indication.
The number of successful risk indications was scored and
normalized to the maximal number of possible risk indications by
calculation of the RIS (Equation (6)).
RIS ½% ¼
P
#RQE1; E2; EE2 > 1 and BEQ > EBT

x100P
#RQE1; E2; EE2 > 1
(6)
In a few cases, an EBT exceedance was observed where cumu-
lative chemical RQE1E2EE2 was <1. This was scored as “ncr (no
chemical risk indication, but positive biological response) and an
“ncr* screening score” was calculated (Equation (7)).
ncr* ½% ¼
P
#RQE1; E2; EE2 < 1 and BEQ > EBT

x100P
#RQE1; E2; EE2 > 1
(7)
RIS and ncr* score were calculated using three proposed EBTs.
The two parameters identify the speciﬁcity of effect-basedmethods
to predict risks caused by steroidal estrogens and their potential as
screening methods. This screening allows to detect additional risks
caused by estrogen receptor activating substances other than ste-
roidal estrogens or where chemical analysis was not able to
quantify steroidal estrogens due to high LOQs.3. Results and discussion
3.1. Compliance assessment with chemical analytical methods
Here we describe the results of our compliance assessment
based on chemical analytical data. Results of the chemical analysis
of surface water and efﬂuent samples tested in this study including
LOD and LOQ values are provided in SI Tables 1e3 and by
K€onemann et al. [36].
On average, SW water samples had a much higher percentage
of compliant samples compared to WW samples (54% SW vs. 12%
WW, Table 1). Due to matrix effects and associated higher LOD/
Table 1
Chemical analytical compliance assessments of 16 surface water (SW) samples and
17 wastewater (WW) samples, which were analysed by HPLC MS/MS methods.
Compliance frequency is shown as percentage, arithmetic mean and coefﬁcient of
variation (CV). Analytical data is provided in SI Tables 1e3.
Lab1 [%] Lab2 [%] Lab3 [%] Mean ± CV [%]
SW compliant samples 44 63 56 54.2 ± 9.5
SW non-compliant samples 31 25 38 31.3 ± 6.3
SW not assessable samples 25 12 6 14.6 ± 9.5
WW compliant samples 18 18 0 11.8 ± 10.2
WW non-compliant samples 53 47 41 47.1 ± 5.9
WW not assessable samples 29 35 59 41.2 ± 15.6
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assessed compared to SW samples (15%). For SW and WW
sample assessments, the CV is in the range of 6e10%. Due to
insufﬁcient silica gel clean-up of WW samples, matrix effects
were not reduced in an optimal way. Under ideal conditions,
analytical methods can achieve LODs and LOQs of a factor 2 to 3
lower in WW samples. It has to be recognized that LODs of
chemical analytical methods for steroidal estrogens have been
lowered signiﬁcantly since 2013 and are likely to decrease
further [25,29]. The differences in sample assessment
(“compliant” vs. “non-compliant” vs. “not assessable”) among the
three analytical methods were far more frequently caused by
differences in LOQs rather than by differences in detected con-
centrations (SI Tables 1e3). The percentage of “not assessable”
samples (up to 25% in SW and 59% in WW) conﬁrmed the exis-
tence of challenges for the chemical monitoring of estrogens E2
and especially EE2. Moreover, if the strict requirements of
compliance assessment currently applied to monitoring of pri-
ority substances under the WFD (i.e. the LOQ should be 1/3 of the
EQS [45]), none of the results obtained in this study could be
considered acceptable for compliance assessment of the chemical
status of surface waters.
3.2. Ecotoxicological status assessment with in vitro effect-based
methods
Bioanalytical equivalent concentrations (BEQ), or EEQ for
estrogenicity, are a measure of the effect caused by mixtures of
unknown and potentially unidentiﬁed chemicals expressed as the
equivalent concentration of a known reference compound that
would elicit the same effect as the sample [46]. Effect-based trigger
values (EBT) for in vitro bioassays can be derived by combining
calculated or measured BEQs of selected substances that trigger a
speciﬁc effect, with a benchmark approach using known chemical,
toxicological and biological data [38]. Similar to conventional risk
assessment using chemical concentration and EQS, exceedance of
effect-speciﬁc EBTs indicates an elevated, unacceptable risk (hazard
& exposure) for the aquatic ecosystem due to chemicals with a
particular MoA such as estrogenicity. Measured BEQs below an EBT
indicate a low and acceptable ecological risk.Table 2
In vitro effect-based (ecotoxicological) compliance assessments of 16 surfacewater (SW) a
assessments are shown as percentage, arithmetic mean, and coefﬁcient of variation (CV)
ER-Calux [%] p-YES [%] MELN
SW compliant samples 62 50 50
SW non-compliant samples 38 50 50
SW not assessable samples 0 0 0
WW compliant samples 47 35 24
WW non-compliant samples 53 65 77
WW not assessable samples 0 0 0Similar to the results of chemical methods, a greater percentage
of SW samples (61%) were “compliant” compared to WW samples
(39%) (Table 2). The matrix effects did not lead to any “not assess-
able” categorization and ER mediated estrogenicity was quantiﬁed
in all samples. Results obtained using different effect-based
methods showed good agreement in average status assessments
with CVs of 10e11% in SW and WW samples.3.3. Comparison of status assessment by chemical analytical and
in vitro effect-based methods
The in vitro effect-based methods were less matrix-dependent
and provided generally lower LOQs than chemical analytical
methods (Table 3). As it was mentioned before not all matrix effects
were optimally removed duringWW samples extraction. All results
obtained with in vitro effect-based methods allowed a risk assess-
ment because the LOQ was below the target EBT values for all
samples. Status assessment with chemical analytical and in vitro
effect-based methods showed overlapping values and means. The
main difference in chemical analytical detection methods is the
single substance based approach which can be matrix dependent.
In vitro effect-based methods allow an integrative activity mea-
surement of all ER activating substances and are not matrix inde-
pendent as long no cytotoxic and ant-estrogenic effects occur,
which was not the case in our samples. Therefore the different
responses and LOQs of both method can be compared, a detailed
discussion is available in K€onemann et al. [36].3.4. Comparison of chemical analytical and in vitro effect-based
methods
3.4.1. Mixture risk scenarios of chemical analytical measurements
Since the main MoA of E1, E2, and EE2 is activation of ER, their
interactions in environmental mixtures are most probably con-
centration additive [36]. The risk quotient addition model, which is
derived from the mixture model of concentration addition, was
shown to be sufﬁciently accurate for regulatory use [41]. Therefore,
the sum of individual RQs of E1, E2, and EE2, represents the com-
bined risk for the mixture of E1, E2, and EE2 and is called cumu-
lative RQ. To show full ranges of potential RQs, the minimal, the
medium, and maximal cumulative RQs were thus determined for
each sample.
Depending on the mixture risk scenario, the sum of RQ and
mean percentage of samples at unacceptable risk increased
(Table 4). The minimal cumulative mixture risk scenario showed in
7 SW and 9 WW samples RQs above 1, whereas 9 SW and all WW
samples presented an unacceptable risk in the medium mixture
risk scenario. The maximal possible mixture risk scenario showed
10 out of 16 SW samples and all WW samples RQs above 1. A
dilution factor was not taken into account for theWW samples (see
chapter 3.5.2).nd 17wastewater (WW) samples using an EBTof 400 pg/L EEQ. Results of compliance
. EEQ concentrations are provided in SI Table 4,5.
[%] HeLa 9903 [%] ER-Gene-Blazer [%] Mean ± CV [%]
75 69 61.3 ± 11.2
25 31 38.8 ± 11.2
0 0 0.0
47 35 37.6 ± 9.8
53 65 62.4 ± 9.8
0 0 0.0
Table 3
LOQ comparison of chemical analytical (LOQ for E2) and in vitro effect-based (EEQ corresponding to E2 equivalents) measurements of 16 surface water (SW) and 17 wastewater
(WW) samples. Data are shown as arithmetic mean, range, and coefﬁcient of variation (CV). The measurements are provided in SI Tables 1e5.
Methods LOQSW LOQWW
Mean ± SD [pg/L] Min-max range [pg/L] CV% Mean ± SD [pg/L] Min-max range [pg/L] CV%
3 chemical analytical methods [E2] 181 ± 291 39e1500 161 627 ± 726 50e3000 116
5 in vitro effect-based methods [EEQ] 28 ± 33 2e200 116 60 ± 62 1e216 104
Table 4
Average cumulative risk quotients (RQ) for EE2, E2, and E1 based on mean concentrations of three chemical analytical measurements for 16 surface water (SW) and 17
wastewater (WW) samples calculated for minimal, medium and maximal risk scenarios.
Cumulative RQ for SW samples Cumulative RQ for WW samples
Sample code Minimal Medium Maximal Sample code Minimal Medium Maximal
A (11) 0.02 0.41 0.77 A (26) 0.02 1.78 3.53
B (6) 0.02 0.38 0.72 B (29) 0.03 2.01 3.78
C (1) 0.04 0.45 0.8 C (31) 0.04 7.78 15.48
D (22) 0.04 0.41 0.76 D (4) 0.06 3.45 6.29
E (27) 2.27 2.34 2.38 E (17) 3.49 3.25 5.06
F (30) 0.1 1.77 3.37 F (21) 0.12 2.74 5.32
G (32) 0.28 0.58 0.97 G (14) 0.23 11.2 21.21
H (25) 0.17 1.6 2.62 H (5) 0.58 18.41 34.99
I (8) 0.39 1.21 2.06 I (19) 0.8 5.5 9.75
J (10) 0.37 0.66 0.98 J (16) 7.45 14.54 25.5
K (18) 4.99 4.99 4.99 K (9) 1.49 18.3 34.52
L (24) 1 4.18 7.06 L (13) 4.15 6.93 10.07
M(28) 1.41 4.11 6.36 M(23) 219.18 219.1 219.4
N (15) 2.5 4.99 7.26 N (33) 4.26 15.37 25.69
O (3) 10.71 12.11 16.6 O (12) 4.94 17.01 27.51
P (7) 5.17 5.92 8.19 P (2) 5.6 7.85 9.88
Q (20) 151.6 151.6 151.6
Mean cumulative RQ 1.84 2.88 4.12 Mean cumulative
RQ
23.76 29.81 35.85
Percentage of samples
presenting an unacceptable risk
44% 63% 63% 53% 100% 100%
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compared with in vitro effect based methods
We compared the risk derived for the minimum and the
maximummixture risk scenarios based on chemical analytical data
with risk indicated by the effect based methods. Figs. 1 and 2 show
that the sum of the risk quotients (“mixture risk of steroidal es-
trogens”) derived from chemical measurements were highly
correlated with the measured EEQs in the respective samples.
Depending on the choice of LOD, LOD/2 or 0 to replace non-detects,
the respective cumulative mixture risk estimation (minimal to
maximal) can change considerably (by several orders of magni-
tude) if non-detects occur.
Overall, EEQ measured with the ﬁve in vitro effect-based
methods correctly assigned the “chemical status” of wastewater
samples as determined by the sum of the risk quotients for E1, E2,
and EE2, with highest EEQ signals detected at sites where EE2 was
present at concentrations above the LOQ and thus quantiﬁed. In
most cases, the ﬁt for maximal RQ was worse than for the minimal
scenario indicating that undetected compounds were likely not
present in the mixtures and non-detected compounds did not play
a signiﬁcant role. The signiﬁcant correlations indicate that for our
selection of samples (33 samples from seven countries with vari-
able pollution levels) estrogenicity was mainly caused by the ste-
roidal estrogens E1, E2, and EE2 and anti-estrogenicity or other
xenoestrogens played a minor role. This is supported by the iceberg
modelling presented by K€onemann et al. [36]. However, this result
can be partially inﬂuenced by the choice of more or less speciﬁc
extraction methods.
Even though our results conﬁrmed that the steroidal estrogens
were dominantly responsible for triggering the estrogenic activitiesmeasured by the bioassays, an important question is if the as-
sumptions are applicable to all surface and wastewaters. Although
most studies comparing steroidal estrogen concentrations with
biological activity support the applicability of effect-basedmethods
[13,18,36,38,46,47], there can be some exceptions. In our dataset,
the risk for one SW sample was evaluated as unacceptable in all
three chemical analyses, whereas not by any effect-based method
(Table 5, sample E (27)). In this sample, EE2 was detected in the
range of 73e85 pg/L, which indicated an elevated risk (RQ ¼ 2.27),
while concentrations of E2 and E1 were very low (Table SI 1e3,
sample E (27)). We can explain this by comparing the potential of
E1, E2 and EE2 to induce responses in vitro and in vivo.While E1 and
E2 usually trigger in vitro responses at similar concentrations as
in vivo responses, EE2 is 10e20 times more potent in vivo than
in vitro [33,48]. This is reﬂected in very low EQS of EE2, but in
contrast to the relatively high EBT, which integrates the risk of
chemical mixtures. The precautionary principle (to work with EE2-
equivalents and an EBT of 35 pg/L) cannot be applied here, because
then all samples including background samples [26,38,49] would
be assessed as presenting an elevated risk. Since the main source of
EE2 is its excretion after use of contraceptive pills, however, EE2 is
usually present together with other natural steroidal estrogens, and
risk is therefore correctly indicated by results of effect based
methods and the proposed EBT. Sample E (27) appears to be an
exception as other WW samples (Q (20), M(23)) contained rela-
tively high concentrations of EE2 (which contributed to more than
93% of cumulative RQ) and high EEQs were measured in all ﬁve
in vitro effect-based methods due to the mixture effects in the
samples. However, in the aquatic environment EE2 degrades less
rapidly than the natural hormones [50] and may still be present
Fig. 1. Minimal and maximal cumulative risk quotients (RQ) compared with measured ER-Calux, pYES, MELN, Hela 9903, ER-GeneBlazer biological responses of ER activation [EEQ
in pg/L] in 16 surface water (SW) samples. The in vitro effect-based methods are shown vertically from row 1 to 5. All correlations shown in the ﬁgures are highly signiﬁcant with
p < 0.0001 (SI Table 13).
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Fig. 2. Minimal and maximal cumulative risk quotients (RQ) compared with measured ER-Calux, pYES, MELN, Hela 9903, ER-GeneBlazer biological responses of ER activation [EEQ
in pg/L] in 17 wastewater (WW) samples. The in vitro effect-based methods are shown vertically from row 1 to 5. All correlations shown in the ﬁgures are highly signiﬁcant with
p < 0.0001., only pYES graph at maximal risk had p < 0.01 (SI Table 14).
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Table 5
Mean positive risk indication scores (RIS) and coefﬁcients of variations (CV) of the 5
in vitro effect-based methods for the identiﬁcation of population relevant risks
(RQs>1) applying different trigger values (EBT) 300, 400 and 500 pg/L. Additionally
the percentage of positive biological responses without chemical veriﬁcation (ncr*)
was calculated. Data were used from SI Tables 10e12.
EBT approach Risk indication of
steroidalestrogens RIS [%]
Screening of other
xenestrogens and
unquantiﬁable steroidal
oestrogens
Mean percentage of ncr*
related to chemical positives
[%]
SW CV WW CV SW CV WW CV
EBT ¼ 300 pg/L 82.9 6.4 93.3 6.1 25.7 35.6 33.3 13.6
EBT ¼ 400 pg/L 77.1 12.8 91.1 5.0 11.4 15.7 26.7 14.9
EBT ¼ 500 pg/L 65.7 21.7 84.4 9.9 2.2 4.9 20.0 16.4
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could be missed both by chemical analysis and effect-based
methods, but for effect-based methods the test speciﬁc relative
potency for EE2 can be considered and further reﬁnements in EBT
are possible. EE2 alone can also be discharged by industrial sources,
but such sources can be expected to discharge concentrations far
above EBT which could be detected by in vitro effect-based
methods.
In theory, anti-estrogenic compounds could modulate ER activ-
ity and, therefore, interfere with EEQ measurements. While most
literature focuses on agonistic (estrogenic) modes of action, sub-
stantially less information is available on anti-estrogenic MoA in
environmental waters [51]. Overall, anti-estrogens are not consid-
ered to be amajor issue in commonmunicipalWW [33]. So far, anti-
estrogenic activity has not been commonly detected in environ-
mental waters by effect-based methods and many limitations exist
in measuring anti-estrogenic effects (lack of standardization, and
potential artefact problems due to DOC) [48]. The highly signiﬁcant
correlation between measured estrogens and bioassay results
found in this study supports the hypothesis that anti-estrogenic
substances or other ER-receptor activating substances play a mi-
nor role in WW and SW samples containing WW (Figs. 1 and 2).
Given that the EQS values of the steroidal estrogens are based on
population-relevant long-term effect data (the EQS were derived
from Species Sensitivity Distribution based on data from 9 to 11 ﬁsh
species), the mixture risk can be considered as directly indicative
for population-relevant effects in ﬁsh species. As a consequence,
the (receptor activation-based) biological response measured with
the bioassays, which was highly correlated with cumulative RQs
(Figs. 1 and 2), can also be considered to estimate the risk for
aquatic species. Therefore, we investigated whether the biological
EEQ response exceeded the EBT of 400 pg/L in those cases where a
cumulative population relevant mixture-risk was identiﬁed.
3.4.3. Risk indication of in vitro effect-based methods for
cumulative population relevant effects
The risk indication for all three EBT scenarios was calculated in
the SI Tables 10e12 and showed a good agreement of chemical and
biological risk indicators. For the moderate EBT of 400 pg/L the
relative RIS (score of biological responses which indicates quanti-
ﬁable chemical mixture risk) of all ﬁve in vitro assays was 77%± 13%
CV for SW samples and 91% ± 5% CV forWW samples. There are two
reasons for the higher percentage of RIS in WW. First, there is
naturally higher variability in the evaluation of samples with lower
activities, such as SW compared to WW (EEQs close to the EBT can
result in different category). Second, the composition of municipal
wastewaters in Europe have been shown to typically contain ste-
roidal estrogens with EE2 contributing 40% of total estrogenic
activity (EEQ) [33]. As discussed above, the bioassays indicate the
risks most precisely when EE2 is not the predominant estrogenicity
driver but occurs in combination with other steroids (chapter
3.4.2).
Our results also demonstrate the potential of the effect-based
methods to screen samples for other estrogens than the three
target compounds. For example, two WW samples were evaluated
as “compliant” or “not assessable” when their RQ were calculated
based on chemical data (SI Table 11, samples G (14) and I (19)),
however, most bioassays indicated elevated risk. Themost probable
reason is that the screening function of bioassays is not limited to
steroidal estrogens and conﬁrms ﬁndings of recently published
approaches for screening endocrine active pharmaceuticals and
other receptor activating substances [20,21,25]. In this study, the
screening for other receptor activating compounds was measured
by an ncr* score (the relative positive risk indication without
chemical analytical veriﬁcation ratio normalized to the number ofchemical positive ﬁndings) and resulted in 11.4% “biological posi-
tives” for SW samples and 26.7% for WW samples. In other words,
with the selected EBT, the effect-basedmethodswere able to screen
11e27% more positive samples for SW and WW.
Finally, one of the in vitro effect-based methods (HeLa 9903)
occasionally showed EEQs below the EBT where all other bio-
assays and chemical methods showed a risk (SI Table 11, SW
samples P (7), M(28)). Variability can generally account for some
negative risk indications, which occur when the detected EEQs
are close to the EBT. These samples contained very high con-
centrations of E1. E1 is typically a less potent ER ligand than E2,
but it is particularly less potent in HeLa 9903 with an estrogenic
potency relative to E2 of 0.018 (the relative potencies of other
used in vitro effect-based methods are listed in the SI Table 5 of
the companion publication [36]), and thus the contribution of E1
to EEQ was lower than for most other bioassays with exception
ER-Calux. Low potencies and higher variabilities, which are
indicated by LOQs can lead to reduced detectability by some
bioassays, and test speciﬁc reﬁnements should be considered.
This is also a matter of identifying criteria for benchmarking of
bioassays suitable for these application purpose and to add test
speciﬁc “sensitivity factors” which can be multiplied with EEQs to
meet a screening EBT. This was identiﬁed as a future need and
included as one of the aims of a subsequent project (see Con-
clusions and Outlook).
3.4.4. Comparison of trigger value (EBT) scenarios to assess the risk
indication of in vitro effect-based methods
Different trigger values were applied to assess risk indication
and screening function of used methods. Results provided in
chapter 3.4.3 show that an EBT of 400 pg/L can distinguish with
high precision (77% ± 13%e91% ± 5%) between more and less
polluted SW and WW sites, indicated by a quantiﬁable population
relevant mixture risk. To investigate the impact of the choice of EBT
on results all three proposed EBT, 300 pg/L EEQ [33], 400 pg/L EEQ
[25,26] and 500 pg/L EEQ [38] were compared.
Application of the lowest EBT of 300 pg/L resulted in the highest
RIS of 83 ± 6% for SW samples, and 93 ± 6% forWW samples, as well
as in the highest ncr* scorewith 26% for SWand 33% forWW. Use of
the moderate EBT of 400 pg/L led to slightly (2e6%) lower RIS for
WW and SW samples, compared to the strictest EBT scenario of
300 pg/L. On the other hand, the moderate EBT scenario reduced
the ncr*to half for SW (11%) and to two thirds for WW (27%),
compared to the strictest EBT scenario. The least stringent EBT of
500 pg/L lowered the RIS for WW and SW samples to 8% and 16%,
respectively, compared to the strictest EBT scenario. The ncr* score
decreased to 2% in SW and 20% in WW. The ncr* score can vary
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mixtures.
Generally the ncr* should allow screening for non-target ER
receptor-activating substances. A high ncr* as shown in our strictest
EBT scenario would mean that there was a need for additional
analyses by costly high end chemical analytical methods (26e33%).
Application of a higher EBT of 500 pg/L results in a low ncr*. (2% in
SW) indicating that samples containing unknown estrogens will
not be selected. The moderate EBT scenario means that fewer (half
to one third) samples have to be analysed further by chemical
analysis. This moderate EBT scenario is still quite protective and
speciﬁc with 77e91% of positive RIS based on quantiﬁed chemical
analytical mixture risks. The moderate EBT scenario of 400 pg/L
EEQ has an additional screening function for other non-target ER
activating substances, combined with a high speciﬁcity for the risks
of steroidal estrogens.
3.4.5. Speciﬁcity and sensitivity of chemical analytical and in vitro
effect-based methods in compliance assessments
A suitable method should be speciﬁc and sensitive. A speciﬁcity
and sensitivity analysis was therefore performed with each
methods applied in this study in order to characterize and compare
their suitability for monitoring (Fig. 3AB).
For SW samples the three chemical analytical methods per-
formed with moderate speciﬁcity >73% and moderate sensitivity
>69%. The Lab3 method achieved higher sensitivity of 75% and the
Lab2 method achieved the highest speciﬁcity level of close to 85%.
The ﬁve in vitro effect-based methods had, in most cases, high
speciﬁcity and high sensitivity >90% in SW. Only the sensitivity of
one method HeLa 9903 was lower (66.7%). ER-Calux, p-YES and
MELN were the most sensitive assays (100% sensitivity), and ER-
Calux, HeLa 9903 and ER-ER-GeneBlazer had the highest speci-
ﬁcity (100%).
For WW samples, the chemical analytical methods performed
with low speciﬁcity (in a range of 52e56%) and with low to mod-
erate sensitivity (59e67%), likely due to matrix effects which were
not removed efﬁciently by the silica gel cleaning step (see methods
section 2.1). Most in vitro effect-based methods performed well in
WW and showed both high speciﬁcity and high sensitivity >85%.
Only the p-YES and MELN were less speciﬁc with 71% and 57%
speciﬁcity, respectively. This can be explained by the higher
sensitivity for E1 of both methods. For WW, MELN and ER-ER-
GeneBlazer were the most sensitive assays (100% sensitivity), and
ER-Calux and HeLa 9903 were the most speciﬁc. Finally, most
(exception of MELN and pYES in SW which performed similarly)
(Fig. 3 AB). This can be explained by the quantiﬁcation problems of
HPLC MS/MS that often occurred in WW and in some SW samples
(SI Tables 1e3 and 6,7).Fig. 3. AB: Speciﬁcity and sensitivity assessment of three analytical LC MS/MS methods (La
applied in this study. Results are given as relative values in % for 16 surface water sampl
assessment. A high speciﬁcity indicates if a method is less prone to false positive assessmen3.4.6. Comparability of chemical analytical and in vitro effect-based
methods
A recent literature review [52] highlighted the need for sufﬁ-
ciently sensitive analytical methods for E2 and EE2 in order to be
able to comply with the WFD reporting requirements [8,9]. Our
study applied advanced analytical methods and conﬁrmed this
ﬁnding. The main advantages of chemical analytical methods are
the quantiﬁcation of single analytes, however, for both E2 and EE2
LOQs were often >EQS. Chemical analytical methods were able to
detect steroidal estrogens above their EQS in 56% of SW samples
and only in 16% of WW samples [36], demonstrating that the
chemical analytical detection of E2 and EE2 is currently at the limit
of feasibility with advanced methods. First monitoring results of
the EUwatch-list substances in 2017 conﬁrm these results. In 21 EU
member states the LOQs for EE2 E2 were above their EQS in >95%
and approx. 50% of unquantiﬁed water samples analysed. In our
study, if steroidal estrogens were detected, the average coefﬁcients
of variation CV % of quantiﬁable concentration measurements in
SW (for E1 ¼ 22.2%, E2 ¼ 28.3%, EE2 ¼ 15.8%) and WW (for
E1 ¼ 18.9%, E2 ¼ 36.2%, EE2 ¼ 14.6%) showed good agreement be-
tween the three chemical analytical analyses (SI Tables 1e3), but
the methods showed also signiﬁcant absolute variability in LOQs
(Table 3) making a comparable risk-assessment difﬁcult.
Overall, in vitro effect-based methods were highly sensitive
(90e94%) and speciﬁc (83e92%) in both SW and WW assessments
(Fig. 3AB). The main advantage of the in vitro effect-based methods
is their ability to account for the mixture toxicity and integrate the
effects of unknown chemicals with the sameMoA (e.g. metabolites)
as well as synergistic or antagonistic mixture effects. In our study
the CV of SW and WW sample assessments was in the range of
10e11%, showing good comparability of all ﬁve in vitro methods
regarding the status assessment (Table 2) without any not-
assessable samples.
Variability of in vitro effect based methods is similar to that of
chemical analytical methods. To quantify intra- and inter-test
variability, ﬁve in vitro effect-based methods were recently
compared [47]. In this comparison the CV of EEQ concentrations
measured in the ﬁve in vitro assays and for all samples was around
32% for comparing artiﬁcial mixtures. CV was lower for intra-day
experiments (30%) compared to inter-day experiments (37%). ER-
Calux had the best precision and repeatability with an overall CV
of 13%. Further validation, inter-laboratory comparison studies and
standardization of these effect-based methods may still improve
their suitability for monitoring (Mehinto et al. [53]). In our study
the ﬁve used in vitro effect-based methods correlated well among
each other as it was shown in the companion publication by
K€onemann et al. [36]. In line with the results of our study, other
studies have also conﬁrmed that in vitro effect-based methods areb 1, Lab 2, Lab 3) and ﬁve in vitro effect-based methods for speciﬁcity and sensitivity
es (A) and 17 wastewater samples (B) and were compared to the overall compliance
ts. A high sensitivity indicates if a method is less prone to false negative assessments.
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correctly [23,54].
The results of our study support the application of in vitro effect-
based methods for surface and especially for WW monitoring. Re-
sults of individual bioassays and chemical analyses correlated
highly (Figs. 1 and 2) demonstrating the suitability of all effect-
based methods to indicate steroidal estrogen pollution with pop-
ulation relevant mixture risks. Our proposed approach for an eco-
toxicological status assessment is in line with the latest results of
the EU project SOLUTIONS from K€onig et al. [21], which measured
pollution patterns in the river Danube using a large set of effect-
based as well as chemical analytical methods. In this study an in-
tegrated analytical-bioanalytical approachwas well suited to detect
the impact of untreated wastewater on Danube River water quality.
Both chemical and biological effect patterns were affected in a
consistent way.
Limitations and recommendations: To prevent overestimation
of these in vitro effect-based methods to protect the environment,
their limitations are summarized as follows:
a) Cell culture based assays cannot account for organism-level
toxicokinetic changes e.g. metabolism. Differences in tox-
icokinetics are likely in less frequently investigated species and
modes of actions might in speciﬁc cases result in over- or un-
derestimations of in vivo effects when evaluated purely by
in vitro effect-based methods with one trigger value. Despite
this our results showed that also the highly potent EE2 was
correctly identiﬁed in mixtures by in vitromethods, see chapter
3.4.3. But generally the chemical analytical approach also does
not consider the toxicokinetics and bioavailability, and EQS are
always limited to available effect-data sets.
b) Although not conﬁrmed in any study including this one, the
interaction of the generally much less potent (compared to the
steroidal estrogens) anti-estrogenic compounds could lead to
underestimation of risks of estrogenicity cannot be excluded for
very speciﬁc sample compositions. In case if high concentrations
of anti-estrogenic substances would bind to ER receptor the
detection of ER-agonists can be lowered.
Considering these limitations and options, we recommend
direct use of in vitro effect-based methods with a preliminary
screening EBT of 400 pg/L EEQ under the WFD for the following
pragmatic reasons: a) there are currently no better available tools to
monitor this type of endocrine disruptor pollution providing
important link between MoA and adverse effects, b) they will
circumvent current monitoring problems of steroidal estrogens, c)
the methods are cost-efﬁcient and can decrease the ﬁnancial
burden of monitoring, d) they are readily available, e) they address
mixture effects.
3.4.7. Risk management
3.4.7.1. Surface water risk management options. The development
of analytical techniques to detect EDCs in environmental matrices
still remains one of the main challenges for environmental chem-
ists [54,55]. Due to analytical difﬁculties in the last decades no
representative EU-wide monitoring dataset is available and risk
characterizations are mainly known from modelling. For example
Johnson and colleagues [1] estimated at median ﬂow conditions an
average an EQS exceedance of EE2 in 12% by length of Europe's
rivers, which can in some countries also be higher than 30%. This
single substance related population relevant risk is certainly
increased by other ER activating substances.
One of the main recommendations (in view of the future review
of theWFD) is to integrate effect-basedmethods into monitoring of
water quality and to adopt them as a key approach for addressingchemical mixtures interactions with aquatic organisms [16]. Our
study supports this recommendation: speciﬁc effect-based
methods proved to be suitable tools to indicate the risks associ-
ated to the quantiﬁed and unquantiﬁed fractions of EE2, E2, and E1
for various water samples and should therefore be applied as
screening tools to identify polluted waterbodies. Especially because
of the low LOQs and low absolute variability in LOQs they are
reliable and suitable regarding risk assessments and prioritizations.
Besides, effect-based methods are the only currently available
tools to address unknown mixture risks and circumvent the
monitoring limitations of current chemical analytical methods, as
mentioned above. But another question needs to be solved for risk
management: How to proceed when an EBT is exceeded?
First of all, an EBT exceedance can identify waterbodies at risk
for receptor-mediated estrogenicity. This can allow focusing of
monitoring resources on priority sites. For example, if 100 water-
bodies are screened and only 10% are at risk, for 90% of remaining
waterbodies no costly high-end chemical analysis needs to be
performed. Taking into account our chemical analytical ﬁndings for
SW assessment: 54% ± 10% of the samples were rated as
“compliant”, 31% ± 6% “non-compliant” and 15% ± 10% “not-
assessable” due to too high LOD/LOQ (Table 1). With effect-based
methods, the results overlapped with those obtained with analyt-
ical methods, (61% ± 11% of the samples assessed as “compliant”
and 39% ± 11 “non-compliant” at an EBT of 400 pg/L EEQ) (Table 2),
but thanks to the shift from chemical analytical assessments to an
ecotoxicological effect-based assessment, the percentage of not
assessable samples can be reduced to zero with an obvious beneﬁt
in terms of assessment feasibility and costs.
Secondly, the choice is given to use directly the EBT RQ (Equa-
tion (4) in chapter 2.6) for an ecotoxicological status assessment or
if additionally an identiﬁcation of substances for an investigative
purpose is needed, e.g. via application of mini Effect-Directed
Analysis (EDA), but this would deﬁnitely increase the costs. A cost
estimation for a mini EDA for ER activation is in the range of 5 k
Euro per sample (pers. communication Timo Hamers VU University
of Amsterdam). Based on our study, if a ecotoxicological risk is
identiﬁed, we suggest to mitigate if possible the risk or to identify
the cause substance. Considering the current costs of mini-EDAs for
substance identiﬁcation and the high probability that most of the
effects of concern are caused by mixtures this favours a direct risk
reduction. An ecotoxicological effect-based assessment can be
established if in the EU context the EBT is harmonized and highly
validated and comparable effect-based methods are used for
screening. In this study, we characterized and discussed the
screening value of in vitro effect-basedmethods. Most of the in vitro
effect-based methods are less expensive compared to high-end
chemical analytical methods considering installation costs and
analysis costs per sample. A short cost discussion subchapter is
provided in the SI.
3.4.7.2. Wastewater risk management options. Although no legal
discharge limits for micropollutants exist at the EU level [31], WW
are often monitored as the main known sources of these com-
pounds to waterbodies. Jarosova and colleagues [33] compiled data
of 353wastewatermeasurements from three studies with amedian
concentration of 7e12 ng/L E1, 1.3e1.7 ng/L E2 and 0.47e0.6 ng/L
EE2, so it will depend on the dilution factor and the background
concentration of the receiving water if the EQS can be met and
population relevant risks can be excluded. Also, several activities
aim at limiting unnecessary risks of pharmaceuticals, such as the
EU Strategy on pharmaceuticals [8] which aims at reducing dis-
charges, emissions, and losses, or the Eco-Pharmaco-Stewardship
Initiative for industrial wastewaters [48]. Our study identiﬁed a
high RIS (mean 91%) of 5 in vitro effect-based methods for WWand
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estrogens in these samples because of their complex matrix
composition. This offers a direct use of effect-based methods to
WW risk regulation at local, national, and EU-wide level. This is of
special importance, as the main entrance pathway of the synthetic
EE2 as well as the overall ER-mediated estrogenicity into our
waterbodies is municipal WW. ER-mediated estrogenicity in WW
can be reduced by around a factor of 10 with additional wastewater
treatment techniques and the in vitro effect-based methods can be
also used to monitor these technical options to reduce the phar-
maceutical and anthropogenic mixture risks before entering the
aquatic environment [56e58].
Without knowledge of the ER mediated estrogenicity risk in the
receiving waterbody, we suggest using the same ecotoxicological
status assessment for WW as for SW to ensure an assessment
compliance, because a compliant WW cannot lead to a change in
SW compliance assessment to a non-compliant assessment. With
further knowledge about the ER mediated estrogenicity in the
receiving waterbody the EEQ of WW can be combined with a
dilution factor to estimate a more appropriate overall ER mediated
estrogenicity RQ in SW (Equation (8)). Similarly, for chemical
analytical cumulative risk assessment, the combined risk can be
calculated with a dilution factor and Measured Environmental
Concentrations MEC (Equation (9)).
RQ effect based ¼ WW EEQ
EBT
*
1
dilution factor
þ SW EEQ
EBT
*ð1 1=dilution factorÞ (8)
RQ chem ¼

WWMEC EE2
EQS EE2
þWWMEC E2
EQS E2
þWWMEC E1
EQS E1

*
1
dilution factor
þ

SWMEC EE2
EQS EE2
þ SWMEC E2
EQS E2
þ SWMEC E1
EQS E1

*ð1 1=dilution factorÞ (9)
Because we intended a 1:1 comparability in SW vs. WW assess-
ments, our sampling locations had varying dilution factors, and we
had, in most cases, too limited knowledge about the EEQ in the
receiving water, we used the simpliﬁed Equation (4) (Methods 2.6)
for our calculations. For further studies, another practical solution
would be tomeasureEEQdirectly in themixing zoneof the receiving
waterbody, meaning one EEQ for one ecotoxicological assessment.
4. Conclusions and Outlook
Considering their relevance, applicability for screening as well
as limitations, we propose the application of effect-based methods
under the WFD, in particular the use of in vitro effect based
methods for identifying ER-mediated risk in WFD monitoring
programs. The methods are: I) capable of addressing relevant
combined mixture effects, II) able to overcome detection problems
encountered with analytical techniques for the EU watch list sub-
stances (EE2 and E2), III) suitable as screening tools for the iden-
tiﬁcation and prioritization of waterbodies requiring further
examination, and IV) suitable for measuring ecotoxicological status
in relation to receptor-mediated estrogenicity, one of the most
relevant MoA of EDCs.
A recent study [16] emphasized the need for the harmoniza-
tion and standardization of EBT. The derivation of EBT is one ofthe tasks identiﬁed for the activity on effect-based methods
started by the EU Working Group Chemicals under the Common
Implementation Strategy for the WFD [59]. The results of our
study conﬁrm that a preliminary screening EBT of 400 pg/L EEQ is
suitable for the identiﬁcation of population relevant analytical
(and mixture) risks from steroidal estrogens, at the same time as
achieving the screening of other ER-activating substances. This
EBT is recommended as a suitable threshold or cut-off value to
discriminate samples of greater level of estrogenic pollution with
the aim of classifying waterbodies. The application of this value
can be further reﬁned, taking into account differences in sensi-
tivity of the used methods via sensitivity factors and risk
classiﬁcations.
Our study demonstrated SW andWW risk management options
by using risk indication scores (RIS) based on tested EBT covering
population relevant effects for aquatic organisms. The tested con-
cepts proved to be applicable for WW and for most SW (91% of RIS
vs. 77% of RIS). Effect-based methods were highly sensitive
(90e94%) and speciﬁc (83e92%) in both SW and WWassessments.
In special situations where EE2 occurs at low, yet EQS-exceeding,
concentrations and alone mainly contributes to ER-mediated
estrogenicity, a false negative assessment might occur. This issue
was only discovered in one of 16 SW or in total 33 samples. Based
on the highly signiﬁcant correlations between all measured estro-
gens risks and bioassay results found in this study (Fig. 1þ 2) it was
possible to identify that anti-estrogenicity and matrix effects
played a minor role in most of our samples. This presented
approach allows us to screen, prioritize, and manage environ-
mental samples using the ER-EBT concept very similar and
compatible to the current chemical status assessment of the WFD.
Furthermore, ER-Calux, A-YES, and L-YES will be standardized at
DIN/EN/ISO level by early 2018 supporting their availability for
regulatory use. Our study showed the use of very speciﬁc in vitro
effect-based methods with tested EBT is able to bridge the gap
between conventional analytical and effect-based monitoring and
risk assessment for steroidal estrogens.
The combination of the results of this study demonstrates that
water quality assessment can progress from a purely analytical
approach to effect-based monitoring, from single substance to
known and unknown mixture assessment, and from in vitro
screening to population-relevant risk assessment. This approach
can support the introduction of the proposed new holistic approach
to the regulation of chemicals in the aquatic environment under the
EU Water Framework Directive, an objective which EU water di-
rectors agreed in November 2016 to investigate [60] and which has
also been recommended by international platforms such as, the
NORMAN network and the EU-funded SOLUTIONS project [16]. A
follow-up study regarding the use of different effect-based
methods under the EU watch list mechanism in 2017 and 2018 is
intended. This follow-up study aims to characterize the screening
function for ER-mediated effects with regulatory relevant EU watch
list samples. Moreover, it intends to apply an integrative effect-
based approach for other relevant pharmaceutical MoA such as
COX inhibition [61,62].
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